Two Biotech CEOs Charged In Securities Fraud Schemes
The U.S. Department of Justice indicted former CytoDyn Inc. Chief Executive Officer Nader Pourhassan and Chief Executive Officer of Amarex Clinical Research Kazem Kazempour on multiple counts of fraud for their involvement in schemes to defraud investors in CytoDyn Inc.. Acording to court documents, Pourhassan and Kazempour allegedly engaged in a…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Stanford professor pays $29M in fraud caseLogin or create an account
FTX founder consents to extradition to the U.S.
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- GLP1s weight-loss drugs may soon be covered by health insurance under new Washington court ruling
- Baystate, Mercy advocate takeover as public worries about ER waits, delivery rooms, Medicare
- Kansas state employees retain choice of Blue Cross, Aetna for health insurance
- Rob Sand unveils water quality, public health plan
- Mark Farrah Associates Assessed Year-End Health Insurance Segment Membership Trends
More Health/Employee Benefits NewsLife Insurance News
- Symetra Names Jeff Sealey Vice President, Stop Loss Captives
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
More Life Insurance News